Mechanistically, eIF4F promotes pro-SFTPB expression, while pro-SFTPB inhibits the formation of eIF4F complex by binding to eIF4A1, thereby suppressing the translation c-myc and PD-L1 that promote cancer stemness and immune evasion. Here, EIF4A1 is linked to cancer.